Home·Stocks·SLS
SELLAS Life Sciences Group, Inc. Common Stock

SLS

XNAS

SELLAS Life Sciences Group, Inc. Common Stock

Basic Materials · Pharmaceutical Preparations

$9.24
+0.06 (+0.65%)
15-min delayed

Drag to pan · Scroll to zoom · Hover for OHLC

Snapshot
Loading metrics…
About SELLAS Life Sciences Group, Inc. Common Stock

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Employees
13
Country
US
IPO Date
2008-03-12
www.sellaslifesciences.com →
Recent News
Jim Cramer: Buy GE Aerospace, 'Two Thumbs Up' For This Life Sciences Stock
Benzinga · 1d ago
Sellas Life Sciences: The Internal Inconsistency Of An Assumed Positive REGAL Readout
SeekingAlpha · 1d ago
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga · 4d ago
COMMUNITY · $SLS0 theses
POST YOUR TAKE →
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Ask AI about SLSBuild basket with SLSScreener

Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.